Primary record
3-Pyridinecarboxylic acid, mixt. with (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl 2-methylbutanoate
- 库存
- 2,964 克
- 纯度
- 98.3 %
- CAS
- 365453-26-5
化合物标识与属性
- CAS
- 365453-26-5
- PubChem CID
- 151176
- SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C.C1=CC(=CN=C1)C(=O)O
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21.O=C(O)c1cccnc1
名称与同义词
- Advicor
- Nicostatin
- lovastatin
- niacin
- Niacin/lovastatin
- Niacin and lovastatin
- Lovastatin-niacin mixt.
- Lovastatin mixture with niacin
- lovastatin-niacin combination
- AC1L45T9
- SCHEMBL29563383
- DTXSID70190043
- C24H36O5.C6H5NO2
- YVPOVOVZCOOSBQ-AXHZAXLDSA-N
- CID151176
- CID:151176
- Niacin extended-release and lovastatin tablets
- SID:125317220
- C24-H36-O5.C6-H5-N-O2
- LS-188004
- 365453-26-5
- C451780
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate;pyridine-3-carboxylic acid
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate; pyridine-3-carboxylic acid
- 3-Pyridinecarboxylic acid, mixt. with (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl 2-methylbutanoate
- Pyridine-3-carboxylic acid--(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate (1/1)